“The company I’m showing you today is essential to biotech stocks. It’s a ‘biotech-enabler,’” declares the author of today’s article in regards to a firm that produces the materials that biotechs need in order to create and fast-track drug compounds – and whose “shares are now in a ‘breakout’ mode because of supercharged demand related to the race for a coronavirus vaccine.” For more on this company, which recently beat earnings expectations and boosted its outlook, CLICK HERE.